|
|
|
|
|
by jraby3
1074 days ago
|
|
Another commenter posted that going through FDA trials could be ruinously expensive for the company,
which made more sense to me than just looking for recurring revenue. Cavities are a ridiculously huge market without the recurring revenue imo. |
|
At that point, it looks much better on your CV to say "we made this miracle treatment, but the FDA put up hurdles to us getting it to market" rather than "we spent many years but the treatment we made didn't work".